Argitalpenak (55) SOFÍA ZARRAGA LARRONDO argitalpenak

2024

  1. Toward a Fair Adjusted Analysis of Kidney Graft Survival

    Transplantation

2023

  1. Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

    Transplantation Reviews, Vol. 37, Núm. 1

  2. Lymphoproliferative disorders after renal transplantation along 2 decades: A large longitudinal study of 21,546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  3. Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  4. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients

    Nefrologia, Vol. 43, Núm. 5, pp. 531-545

2022

  1. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  2. Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study.

    Transplantation Proceedings, Vol. 54, Núm. 9, pp. 2462-2466

  3. Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients

    Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1847-1855

2021

  1. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry

    American Journal of Transplantation, Vol. 21, Núm. 7, pp. 2573-2582

  2. There Are 33,784 Functioning Kidney Grafts in Spain: Who Monitors Them and How?

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2672-2674

  3. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2305-2315

2020

  1. COVID-19–related Mortality During the First 60 Days After Kidney Transplantation

    European Urology

  2. Complicaciones agudas del trasplantado renal

    Tratado de medicina de urgencias (Ergon), pp. 638-642

  3. Monitoring of Donor-specific Anti-HLA Antibodies and Management of Immunosuppression in Kidney Transplant Recipients: An Evidence-based Expert Paper

    Transplantation, Vol. 104, Núm. 8 2S Suppl 2, pp. S1-S12

  4. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients

    Nefrologia, Vol. 40, Núm. 3, pp. 265-271

  5. Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients

    Transplantation, Vol. 104, Núm. 11, pp. 2225-2233

  6. Use of tocilizumab in kidney transplant recipients with COVID-19

    American Journal of Transplantation, Vol. 20, Núm. 11, pp. 3182-3190

2019

  1. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study

    Transplant International, Vol. 32, Núm. 3, pp. 313-322

  2. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

  3. Early outcomes of kidney transplantation from elderly donors after circulatory death (GEODAS study)

    BMC Nephrology, Vol. 20, Núm. 1